These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18406873)

  • 1. Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.
    Rákosy Z; Vízkeleti L; Ecsedi S; Bégány A; Emri G; Adány R; Balázs M
    Cancer Genet Cytogenet; 2008 Apr; 182(2):116-21. PubMed ID: 18406873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
    Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
    Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
    Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21.
    Beatty BG; Qi S; Pienkowska M; Herbrick JA; Scheidl T; Zhang ZM; Kola I; Scherer SW; Seth A
    Genomics; 1999 Dec; 62(3):529-32. PubMed ID: 10644453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
    Berner JM; Sørlie T; Mertens F; Henriksen J; Saeter G; Mandahl N; Brøgger A; Myklebost O; Lothe RA
    Genes Chromosomes Cancer; 1999 Oct; 26(2):151-60. PubMed ID: 10469453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
    Palmieri G; Cossu A; Ascierto PA; Botti G; Strazzullo M; Lissia A; Colombino M; Casula M; Floris C; Tanda F; Pirastu M; Castello G;
    Br J Cancer; 2000 Dec; 83(12):1707-14. PubMed ID: 11104570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor.
    Pujana MA; Ruiz A; Badenas C; Puig-Butille JA; Nadal M; Stark M; Gómez L; Valls J; Solé X; Hernández P; Cerrato C; Madrigal I; de Cid R; Aguilar H; Capellá G; Cal S; James MR; Walker GJ; Malvehy J; Milà M; Hayward NK; Estivill X; Puig S
    Genes Chromosomes Cancer; 2007 Feb; 46(2):155-62. PubMed ID: 17099875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
    Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
    Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
    Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention of polysomy at 9p23-24 during karyotypic evolution in human breast cancer cell line COLO 824.
    Savelyeva L; Claas A; An H; Weber RG; Lichter P; Schwab M
    Genes Chromosomes Cancer; 1999 Jan; 24(1):87-93. PubMed ID: 9892114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
    Knappskog S; Geisler J; Arnesen T; Lillehaug JR; Lønning PE
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1155-63. PubMed ID: 17001621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
    Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the molecular genetics of malignant melanoma.
    Haluska FG; Housman DE
    Cancer Surv; 1995; 25():277-92. PubMed ID: 8718523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
    Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
    Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
    Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
    Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.